ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC63.02

C63.02

Billable

Malignant neoplasm of left epididymis

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C63.02 is a billable code used to indicate a diagnosis of malignant neoplasm of left epididymis.

Key Diagnostic Point:

Malignant neoplasm of the left epididymis is a rare form of cancer that arises from the epithelial cells of the epididymis, a coiled tube located at the back of the testis responsible for storing and maturing sperm. This neoplasm can present with symptoms such as a painless lump in the scrotum, swelling, or discomfort. Diagnosis typically involves imaging studies such as ultrasound or MRI, and a definitive diagnosis is made through histopathological examination following surgical biopsy. The staging of this malignancy is crucial for determining the appropriate treatment plan, which may include surgical resection, chemotherapy, or radiation therapy. The prognosis depends on the stage at diagnosis, with early-stage tumors generally having a better outcome. Additionally, the impact on fertility should be considered, as treatment may affect sperm production and quality. Patients may require counseling regarding fertility preservation options prior to treatment.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Rarity of the condition leading to limited coding experience.
  • Need for precise staging information for accurate coding.
  • Potential for overlapping symptoms with benign conditions.
  • Variability in treatment approaches affecting documentation.

Audit Risk Factors

  • Inadequate documentation of staging.
  • Failure to document the specific site of the neoplasm.
  • Lack of pathology reports to support the diagnosis.
  • Misclassification of benign conditions as malignant.

Specialty Focus

Medical Specialties

Urology

Documentation Requirements

Comprehensive documentation of clinical findings, imaging results, and treatment plans.

Common Clinical Scenarios

Diagnosis and management of scrotal masses, infertility consultations, and post-operative follow-ups.

Billing Considerations

Urologists must ensure accurate staging and pathology documentation to support coding.

Oncology

Documentation Requirements

Detailed treatment plans, response to therapy, and follow-up care documentation.

Common Clinical Scenarios

Management of malignant neoplasms, chemotherapy administration, and palliative care.

Billing Considerations

Oncologists should document the rationale for treatment choices and any fertility preservation discussions.

Coding Guidelines

Inclusion Criteria

Use C63.02 When
  • According to ICD
  • CM guidelines, C63
  • 02 should be used when the malignant neoplasm is confirmed by pathology
  • It is essential to document the specific site and stage of the neoplasm

Exclusion Criteria

Do NOT use C63.02 When
  • Exclusion criteria include benign neoplasms of the epididymis

Related ICD-10 Codes

Related CPT Codes

54500CPT Code

Orchiectomy, radical, with or without lymphadenectomy

Clinical Scenario

Used when a patient undergoes surgical removal of the affected testis and epididymis.

Documentation Requirements

Operative report detailing the procedure and findings.

Specialty Considerations

Urologists must document the extent of the surgery and any findings related to malignancy.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of malignant neoplasms, improving the accuracy of data collection and reimbursement processes. C63.02 provides a clear distinction for malignant neoplasms of the left epididymis, which was less specific in ICD-9.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of malignant neoplasms, improving the accuracy of data collection and reimbursement processes. C63.02 provides a clear distinction for malignant neoplasms of the left epididymis, which was less specific in ICD-9.

Reimbursement & Billing Impact

reimbursement processes. C63.02 provides a clear distinction for malignant neoplasms of the left epididymis, which was less specific in ICD-9.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the primary treatment for malignant neoplasm of the left epididymis?

The primary treatment typically involves surgical resection, which may be followed by chemotherapy or radiation therapy depending on the stage of the cancer.